Compendia Bioscience Inc. in Ann Arbor, Michigan, has won a $1.3 million Small Business Innovation Research Fast Track award to create a way for scientists to survey micro-RNA data across databases.
Micro-RNA is a new type of non-coding RNA molecule that can provide researchers data on cancer development, progression and metastasis. Despite growing libraries of micro-RNA profiling data, cancer biologists are unable to survey the data across published databases.
Compendia’s Oncomine project will capture, curate and analyze the novel micro-RNA data type to enable cancer researchers to find what they need.
Tech accelerator DreamIt Ventures launches minority-focused program
Is the early stage funding valley of death a myth?
Teleradiology group Foundation adds another $1M in funding
CMXI’s Aldagen acquisition is no exit; stem cell payoff is still down the road
Sign up for MedCity News' e-newsletter, providing medical industry news from across the country.
Sign up
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.
Amy SiegelHow low can you go? Creating value with cheap medical devices
Steven M. Auvil (Sponsored)5 things med tech companies need to know about the Leahy-Smith America Invents Act
Jim TateEscape Hatch for Electronic Submission of CQMs for Meaningful Use
Lisa Suennen2012 JP Morgan Healthcare’s (wo)men’s club is changing in a good way
Joe HageA huge American opportunity waiting to happen
Doug MowenMed tech consolidation brings a need for focus. Here are 2 ways to get it
Comments
Post a comment
No comments yet.
Post a Comment